Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
vactosertib
Description:
Vactosertib is an orally administered small-molecule inhibitor of TGF-β type I receptor kinase studied in cancer and inflammatory disease.
Related topics:
Multiple Myeloma Research and Treatments (12%),
TGF-β signaling in diseases (10%),
Cancer Immunotherapy and Biomarkers (9%),
Pancreatic and Hepatic Oncology Research (8%),
Soft tissue tumor case studies (7%)
OpenAlex ID:
keywords/vactosertib
Novel therapies emerging in oncology to target the TGF-β pathway
2021
·
Byung-Gyu Kim
, Ehsan Malek
, et al.
·
Journal of Hematology & Oncology
·
519
PDF
TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12
2024
·
Jie Chen
, Weibo Feng
, et al.
·
Gastroenterology
·
133
Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study
2019
·
Su Young Jung
, Sunjin Hwang
, et al.
·
Investigational New Drugs
·
76
Penetration Cascade of Size Switchable Nanosystem in Desmoplastic Stroma for Improved Pancreatic Cancer Therapy
2021
·
Xiaozheng Zhao
, Xiao Yang
, et al.
·
ACS Nano
·
71
LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer
2022
·
Donatella Delle Cave
, Silvia Buonaiuto
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
58
PDF
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial
2024
·
Ehsan Malek
, Priyanka S. Rana
, et al.
·
Nature Communications
·
55
PDF
Harnessing the Engineered Probiotic‐Nanosystem to Remodulate Tumor Extracellular Matrix and Regulate Tumor‐Colonizing Bacteria for Improving Pancreatic Cancer Chemo‐Immunotherapy
2024
·
Wei‐Qin Yao
, Wen‐Fang Song
, et al.
·
Small
·
45
Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer
2023
·
Ji Eun Lee
, Pureunchowon Lee
, et al.
·
Biomedicine & Pharmacotherapy
·
41
Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor
2022
·
Jiyoung Park
, Jiwon Choi
, et al.
·
Scientific Reports
·
41
PDF
Targeting transforming growth factor beta signaling in metastatic osteosarcoma
2023
·
Rongrong Ge
, Gavin M. Huang
·
Journal of bone oncology
·
40
Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models
2020
·
Eunji Hong
, Sujin Park
, et al.
·
Scientific Reports
·
40
PDF
Efficacy and safety of vactosertib and pembrolizumab combination in patients with previously treated microsatellite stable metastatic colorectal cancer.
2021
·
Tae Won Kim
, Keun Wook Lee
, et al.
·
Journal of Clinical Oncology
·
38
Association of TGF-β responsive signature with anti-tumor effect of vactosertib, a potent, oral TGF-β receptor type I (TGFBRI) inhibitor in patients with advanced solid tumors.
2018
·
Vicki Leigh Keedy
, Todd Michael Bauer
, et al.
·
Journal of Clinical Oncology
·
37
Population pharmacokinetics of vactosertib, a new TGF-β receptor type Ι inhibitor, in patients with advanced solid tumors
2019
·
Su Young Jung
, Ji Seob Yug
, et al.
·
Cancer Chemotherapy and Pharmacology
·
34
Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity
2024
·
Sung Hee Choi
, Jay Thomas Myers
, et al.
·
癌症:英文版
·
32
PDF
Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors
2023
·
Eunji Hong
, Wojciech Barczak
, et al.
·
Cell Death and Disease
·
31
PDF
Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaques in a Rat Model of Peyronie's Disease
2019
·
Kang-Moon Song
, Doo Yong Chung
, et al.
·
The World Journal of Men s Health
·
30
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II Study
2024
·
Jin-Hee Ahn
, Jeeyun Lee
, et al.
·
Clinical Cancer Research
·
27
PDF
Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer
2022
·
Jiwon Choi
, Jiyoung Park
, et al.
·
Radiology and Oncology
·
22
PDF
Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers
2021
·
Kathleen A Luckett
, Jennifer R Cracchiolo
, et al.
·
Endocrine Related Cancer
·
22
PDF
Vactosertib potently improves anti-tumor properties of 5-FU for colon cancer
2023
·
Maryam Moradi Binabaj
, Fereshteh Asgharzadeh
, et al.
·
DARU Journal of Pharmaceutical Sciences
·
16
PDF
Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis
2023
·
Kyung Bong Ha
, Eun Soo Lee
, et al.
·
Diabetes & Metabolism Journal
·
16
PDF
Immunostimulant nanomodulator boosts antitumor immune response in triple negative breast cancer by synergism of vessel normalization and photothermal therapy
2023
·
Hao Jiang
, Yilang He
, et al.
·
Nano Research
·
12
Targeting TGF beta receptor 1 in head and neck squamous cell carcinoma
2023
·
Bernhard J. Jank
, Julia Schnoell
, et al.
·
Oral Diseases
·
12
PDF
Therapeutic Implications of TGF-β Pathway in Desmoid Tumor Based on Comprehensive Molecular Profiling and Clinicopathological Properties
2022
·
Kum-Hee Yun
, Changhee Park
, et al.
·
Cancers
·
11
PDF
Show more works
View as search
Works count:
101
Citation count:
1,668
Year
Topic
Type